Asahi Kasei Pharma
Corporate Profile
Asahi Kasei Pharma is the core operating company of the Asahi Kasei Group for pharmaceuticals, diagnostic reagents, and nutritional products.
| Main businesses | Pharmaceuticals, diagnostic reagents |
|---|---|
| Home office | 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo 101-8101 Japan |
| President | Toshio Asano |
| Paid-in capital | 3,000 million yen |
| Shareholder | Asahi Kasei Corporation |
| (as of April 1, 2010) |
| On October 1, 2008, ownership of Asahi Kasei Kuraray Medical and Asahi Kasei Medical was transferred from Asahi Kasei Pharma, a core operating company of the Asahi Kasei Group, to Asahi Kasei, holding company of the Asahi Kasei Group. |
Major Products
- Elcitonin™, Bredinin™, Flivas™, Toledomin™, and other pharmaceuticals
- Diagnostic reagents
Major Subsidiaries
| Asahi Pharma Spain, SL | Pharmaceuticals | Spain | +34 93 322 40 54 |
|---|
Corporate Officers of Asahi Kasei Pharma
| Toshio Asano | President & Representative Director Presidential Executive Officer |
|---|---|
| Akio Kobayashi | Director Primary Executive Officer |
| Kazuyoshi Hori | Director Senior Executive Officer |
| Katsuto Motoda | Director Executive Officer |
| Yutaka Shibata | Director |
| Tadashi Nagatani | Executive Officer |
| Masayasu Shimazu | Executive Officer |
| Katsunori Horikoshi | Corporate Auditor |
| Hiroki Ideguchi | Corporate Auditor |
| (as of June 16, 2011) |

